46. Malignant rheumatoid arthritis Clinical trials / Disease details

Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00264147 (ClinicalTrials.gov)	January 2006	9/12/2005	Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)	A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Parallel-Group, 12-Week Study to Assess the Clinically Effective Dose Range of Etoricoxib and to Assess Its Safety and Tolerability in Patients With Rheumatoid Arthritis	Rheumatoid Arthritis	Drug: etoricoxib;Drug: Comparator: placebo;Drug: Comparator: diclofenac	Organon and Co	NULL	Completed	18 Years	N/A	All	761	Phase 2	Canada;Colombia;Puerto Rico;Switzerland;United States
2	NCT00092742 (ClinicalTrials.gov)	February 2003	23/9/2004	Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)	A Randomized, Double-Blind, Multicenter Study to Evaluate the Tolerability and Effectiveness of Etoricoxib 90 mg q.d. vs. Diclofenac Sodium 75 mg b.i.d. in Patients With Rheumatoid Arthritis	Rheumatoid Arthritis	Drug: MK0663, etoricoxib;Drug: Comparator: Diclofenac sodium	Organon and Co	NULL	Completed	50 Years	N/A	All	4086	Phase 3	United States
3	NCT00250445 (ClinicalTrials.gov)	January 2003	7/11/2005	A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)	A Randomized, Double-Blind, Active-Comparator-Controlled, Parallel-Group Study to Evaluate the Safety of Etoricoxib in Patients With Osteoarthritis or Rheumatoid Arthritis	Rheumatoid Arthritis,Osteoarthritis	Drug: MK0663, etoricoxib;Drug: Comparator: Diclofenac sodium	Organon and Co	NULL	Completed	50 Years	N/A	All	23498	Phase 3	NULL